• About Us
    • Corporate Profile
    • Global Footprint
    • Our Key Milestones
  • manufacturing
    • Infrastructure
    • Dosage Forms & Capacities
  • products & services
    • Products
    • Services
    • Join Hands With Naxpar
  • Investor relations
    • Financials
    • Shareholders Information
    • Compliance
    • Disclosure under Regulation 46 & 62 of SEBI (LODR) Regulations, 2015
    • Investor Contact
  • Catalogues
    • Naxpar Specialities
    • Naxpar Generics
  • Contact Us
    • Contact Us
    • Adverse Event Reporting
Corporate GovernanceReport

2023 – 2024

PDF
Corporate Governance Report for the Quarter Ended June 2023Download

2022 – 2023

PDF
Corporate Governance Report for the Quarter Ended December, 2022DownloadPDF
Corporate Governance Report for the Quarter Ended March 2023Download

Copyrights Reserved 2008-2023. Naxpar Group